Oppenheimer & Co’s PetMed Express PETS Stock Holding History

Oppenheimer & Co’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,765	Closed	-$375K	–	1557
2021 Q2	$375K	Buy	+11,765	New	+$374K	0.01%	1143

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Oppenheimer & Co's PETS Position: Q3 2021 in Review

Oppenheimer & Co sold out of PetMed Express (PETS) in Q3 2021, closing a stake of 11,765 shares — an estimated $375K sold.

Oppenheimer & Co first reported a position in PETS in Q2 2021 and held it in 1 quarter. The position peaked at $375K in Q2 2021. 193 funds tracked by Wall St. Rank hold PETS as of Q3 2021.

Oppenheimer & Co reported no remaining PetMed Express position as of Q3 2021 after selling out during the quarter.
Oppenheimer & Co sold 11,765 PetMed Express shares in Q3 2021, an estimated $375K.
Oppenheimer & Co first reported a position in PetMed Express in Q2 2021 and held it in 1 quarter.
Oppenheimer & Co's PetMed Express position peaked at $375K in Q2 2021.
193 funds tracked by Wall St. Rank held PetMed Express as of Q3 2021.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.